PubChem CID: 4091
Chemical Structure:
Drug
AMPK
mTOR
IGF/IIS
Epigenetic modification
CR mimetic
Mild mitochondrial poison inducing mitohormesis
Indirect activation of AMPK by inhibiting Complex I in the respiratory chain
Healthspan benefits mimicking caloric restriction, FDA approved clinical trial underway (Targeting Aging with Metformin, TAME). Frontline therapy for type 2 diabetes patients
López-Otín (2013), Sen (2016), Chen (2011), Luengo (2014)